aluates Reports

$ 0.0

Automative

Global Neuraminidase Inhibitor Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-21N8353

Global Neuraminidase Inhibitor Market Insights Forecast to 2028

BUY CHAPTERS

Global Neuraminidase Inhibitor Market Research Report 2025

Code: QYRE-Auto-21N8353

Report

July 2025

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GlaxoSmithKline PLC

Gilead Sciences

F. Hoffman-La Roche

BioCryst

Daiichi Sankyo

Neuraminidase Inhibitor Market

The global market for Neuraminidase Inhibitor was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Influenza viruses are characterized by two surface glycoproteins i.e. hemagglutinnin and neuraminidase. Neuraminidase are the antigens which play an important role in defining the particular strain of influenza. Dosage and safety of neuraminidase inhibitors are the two main parameters, affecting the growth of neuraminidase inhibitors market. The various symptoms of influenza are cough, running nose, fever, headache, fatigue, chills etc. The neuraminidase are recommended for the treatment of the symptoms after the forty eight hours of start of these symptoms.

There are few neuraminidase inhibitors, being sold in the market. The neuraminidase inhibitors have been classified as zenamivir, oseltamivir, peramivir, leninamivir and few other neuraminidase inhibitors. Zenamivir and oseltamivir are the neuraminidase inhibitors which are being used for the treatment of influenza A or influenza B.

North American market for Neuraminidase Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Neuraminidase Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Neuraminidase Inhibitor include GlaxoSmithKline, Gilead Sciences, F. Hoffman-La Roche, BioCryst, Daiichi Sankyo, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Neuraminidase Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuraminidase Inhibitor.

The Neuraminidase Inhibitor market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neuraminidase Inhibitor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Neuraminidase Inhibitor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Neuraminidase Inhibitor Market Report

Report Metric	Details
Report Name	Neuraminidase Inhibitor Market
Segment by Type	Zanamivir Oseltamivir Peramivir Laninamivir
Segment by Application	Hospital Pharmacies Drug Stores Retail Stores Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	GlaxoSmithKline, Gilead Sciences, F. Hoffman-La Roche, BioCryst, Daiichi Sankyo
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neuraminidase Inhibitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neuraminidase Inhibitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Neuraminidase Inhibitor Market report?

Ans: The main players in the Neuraminidase Inhibitor Market are GlaxoSmithKline, Gilead Sciences, F. Hoffman-La Roche, BioCryst, Daiichi Sankyo

What are the Application segmentation covered in the Neuraminidase Inhibitor Market report?

Ans: The Applications covered in the Neuraminidase Inhibitor Market report are Hospital Pharmacies, Drug Stores, Retail Stores, Others

What are the Type segmentation covered in the Neuraminidase Inhibitor Market report?

Ans: The Types covered in the Neuraminidase Inhibitor Market report are Zanamivir, Oseltamivir, Peramivir, Laninamivir

1 Neuraminidase Inhibitor Market Overview

1.1 Product Definition

1.2 Neuraminidase Inhibitor by Type

1.2.1 Global Neuraminidase Inhibitor Market Value Comparison by Type (2024 VS 2031)

1.2.2 Zanamivir

1.2.3 Oseltamivir

1.2.4 Peramivir

1.2.5 Laninamivir

1.3 Neuraminidase Inhibitor by Application

1.3.1 Global Neuraminidase Inhibitor Market Value by Application (2024 VS 2031)

1.3.2 Hospital Pharmacies

1.3.3 Drug Stores

1.3.4 Retail Stores

1.3.5 Others

1.4 Global Neuraminidase Inhibitor Market Size Estimates and Forecasts

1.4.1 Global Neuraminidase Inhibitor Revenue 2020-2031

1.4.2 Global Neuraminidase Inhibitor Sales 2020-2031

1.4.3 Global Neuraminidase Inhibitor Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Neuraminidase Inhibitor Market Competition by Manufacturers

2.1 Global Neuraminidase Inhibitor Sales Market Share by Manufacturers (2020-2025)

2.2 Global Neuraminidase Inhibitor Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Neuraminidase Inhibitor Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Neuraminidase Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Neuraminidase Inhibitor, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Neuraminidase Inhibitor, Product Type & Application

2.7 Global Key Manufacturers of Neuraminidase Inhibitor, Date of Enter into This Industry

2.8 Global Neuraminidase Inhibitor Market Competitive Situation and Trends

2.8.1 Global Neuraminidase Inhibitor Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Neuraminidase Inhibitor Players Market Share by Revenue

2.8.3 Global Neuraminidase Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Neuraminidase Inhibitor Market Scenario by Region

3.1 Global Neuraminidase Inhibitor Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Neuraminidase Inhibitor Sales by Region: 2020-2031

3.2.1 Global Neuraminidase Inhibitor Sales by Region: 2020-2025

3.2.2 Global Neuraminidase Inhibitor Sales by Region: 2026-2031

3.3 Global Neuraminidase Inhibitor Revenue by Region: 2020-2031

3.3.1 Global Neuraminidase Inhibitor Revenue by Region: 2020-2025

3.3.2 Global Neuraminidase Inhibitor Revenue by Region: 2026-2031

3.4 North America Neuraminidase Inhibitor Market Facts & Figures by Country

3.4.1 North America Neuraminidase Inhibitor Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Neuraminidase Inhibitor Sales by Country (2020-2031)

3.4.3 North America Neuraminidase Inhibitor Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Neuraminidase Inhibitor Market Facts & Figures by Country

3.5.1 Europe Neuraminidase Inhibitor Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Neuraminidase Inhibitor Sales by Country (2020-2031)

3.5.3 Europe Neuraminidase Inhibitor Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Neuraminidase Inhibitor Market Facts & Figures by Region

3.6.1 Asia Pacific Neuraminidase Inhibitor Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Neuraminidase Inhibitor Sales by Region (2020-2031)

3.6.3 Asia Pacific Neuraminidase Inhibitor Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Neuraminidase Inhibitor Market Facts & Figures by Country

3.7.1 Latin America Neuraminidase Inhibitor Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Neuraminidase Inhibitor Sales by Country (2020-2031)

3.7.3 Latin America Neuraminidase Inhibitor Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Neuraminidase Inhibitor Market Facts & Figures by Country

3.8.1 Middle East and Africa Neuraminidase Inhibitor Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Neuraminidase Inhibitor Sales by Country (2020-2031)

3.8.3 Middle East and Africa Neuraminidase Inhibitor Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Neuraminidase Inhibitor Sales by Type (2020-2031)

4.1.1 Global Neuraminidase Inhibitor Sales by Type (2020-2025)

4.1.2 Global Neuraminidase Inhibitor Sales by Type (2026-2031)

4.1.3 Global Neuraminidase Inhibitor Sales Market Share by Type (2020-2031)

4.2 Global Neuraminidase Inhibitor Revenue by Type (2020-2031)

4.2.1 Global Neuraminidase Inhibitor Revenue by Type (2020-2025)

4.2.2 Global Neuraminidase Inhibitor Revenue by Type (2026-2031)

4.2.3 Global Neuraminidase Inhibitor Revenue Market Share by Type (2020-2031)

4.3 Global Neuraminidase Inhibitor Price by Type (2020-2031)

5 Segment by Application

5.1 Global Neuraminidase Inhibitor Sales by Application (2020-2031)

5.1.1 Global Neuraminidase Inhibitor Sales by Application (2020-2025)

5.1.2 Global Neuraminidase Inhibitor Sales by Application (2026-2031)

5.1.3 Global Neuraminidase Inhibitor Sales Market Share by Application (2020-2031)

5.2 Global Neuraminidase Inhibitor Revenue by Application (2020-2031)

5.2.1 Global Neuraminidase Inhibitor Revenue by Application (2020-2025)

5.2.2 Global Neuraminidase Inhibitor Revenue by Application (2026-2031)

5.2.3 Global Neuraminidase Inhibitor Revenue Market Share by Application (2020-2031)

5.3 Global Neuraminidase Inhibitor Price by Application (2020-2031)

6 Key Companies Profiled

6.1 GlaxoSmithKline

6.1.1 GlaxoSmithKline Company Information

6.1.2 GlaxoSmithKline Description and Business Overview

6.1.3 GlaxoSmithKline Neuraminidase Inhibitor Sales, Revenue and Gross Margin (2020-2025)

6.1.4 GlaxoSmithKline Neuraminidase Inhibitor Product Portfolio

6.1.5 GlaxoSmithKline Recent Developments/Updates

6.2 Gilead Sciences

6.2.1 Gilead Sciences Company Information

6.2.2 Gilead Sciences Description and Business Overview

6.2.3 Gilead Sciences Neuraminidase Inhibitor Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Gilead Sciences Neuraminidase Inhibitor Product Portfolio

6.2.5 Gilead Sciences Recent Developments/Updates

6.3 F. Hoffman-La Roche

6.3.1 F. Hoffman-La Roche Company Information

6.3.2 F. Hoffman-La Roche Description and Business Overview

6.3.3 F. Hoffman-La Roche Neuraminidase Inhibitor Sales, Revenue and Gross Margin (2020-2025)

6.3.4 F. Hoffman-La Roche Neuraminidase Inhibitor Product Portfolio

6.3.5 F. Hoffman-La Roche Recent Developments/Updates

6.4 BioCryst

6.4.1 BioCryst Company Information

6.4.2 BioCryst Description and Business Overview

6.4.3 BioCryst Neuraminidase Inhibitor Sales, Revenue and Gross Margin (2020-2025)

6.4.4 BioCryst Neuraminidase Inhibitor Product Portfolio

6.4.5 BioCryst Recent Developments/Updates

6.5 Daiichi Sankyo

6.5.1 Daiichi Sankyo Company Information

6.5.2 Daiichi Sankyo Description and Business Overview

6.5.3 Daiichi Sankyo Neuraminidase Inhibitor Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Daiichi Sankyo Neuraminidase Inhibitor Product Portfolio

6.5.5 Daiichi Sankyo Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Neuraminidase Inhibitor Industry Chain Analysis

7.2 Neuraminidase Inhibitor Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Neuraminidase Inhibitor Production Mode & Process Analysis

7.4 Neuraminidase Inhibitor Sales and Marketing

7.4.1 Neuraminidase Inhibitor Sales Channels

7.4.2 Neuraminidase Inhibitor Distributors

7.5 Neuraminidase Inhibitor Customer Analysis

8 Neuraminidase Inhibitor Market Dynamics

8.1 Neuraminidase Inhibitor Industry Trends

8.2 Neuraminidase Inhibitor Market Drivers

8.3 Neuraminidase Inhibitor Market Challenges

8.4 Neuraminidase Inhibitor Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

GlaxoSmithKline PLC

Gilead Sciences

F. Hoffman-La Roche

BioCryst

Daiichi Sankyo

List of Tables

Table 1. Global Neuraminidase Inhibitor Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Neuraminidase Inhibitor Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Neuraminidase Inhibitor Market Competitive Situation by Manufacturers in 2024

Table 4. Global Neuraminidase Inhibitor Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Neuraminidase Inhibitor Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Neuraminidase Inhibitor Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Neuraminidase Inhibitor Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Neuraminidase Inhibitor Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Neuraminidase Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Neuraminidase Inhibitor, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Neuraminidase Inhibitor, Product Type & Application

Table 12. Global Key Manufacturers of Neuraminidase Inhibitor, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Neuraminidase Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuraminidase Inhibitor as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Neuraminidase Inhibitor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Neuraminidase Inhibitor Sales by Region (2020-2025) & (K Units)

Table 18. Global Neuraminidase Inhibitor Sales Market Share by Region (2020-2025)

Table 19. Global Neuraminidase Inhibitor Sales by Region (2026-2031) & (K Units)

Table 20. Global Neuraminidase Inhibitor Sales Market Share by Region (2026-2031)

Table 21. Global Neuraminidase Inhibitor Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Neuraminidase Inhibitor Revenue Market Share by Region (2020-2025)

Table 23. Global Neuraminidase Inhibitor Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Neuraminidase Inhibitor Revenue Market Share by Region (2026-2031)

Table 25. North America Neuraminidase Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Neuraminidase Inhibitor Sales by Country (2020-2025) & (K Units)

Table 27. North America Neuraminidase Inhibitor Sales by Country (2026-2031) & (K Units)

Table 28. North America Neuraminidase Inhibitor Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Neuraminidase Inhibitor Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Neuraminidase Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Neuraminidase Inhibitor Sales by Country (2020-2025) & (K Units)

Table 32. Europe Neuraminidase Inhibitor Sales by Country (2026-2031) & (K Units)

Table 33. Europe Neuraminidase Inhibitor Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Neuraminidase Inhibitor Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Neuraminidase Inhibitor Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Neuraminidase Inhibitor Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Neuraminidase Inhibitor Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Neuraminidase Inhibitor Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Neuraminidase Inhibitor Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Neuraminidase Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Neuraminidase Inhibitor Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Neuraminidase Inhibitor Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Neuraminidase Inhibitor Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Neuraminidase Inhibitor Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Neuraminidase Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Neuraminidase Inhibitor Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Neuraminidase Inhibitor Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Neuraminidase Inhibitor Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Neuraminidase Inhibitor Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Neuraminidase Inhibitor Sales (K Units) by Type (2020-2025)

Table 51. Global Neuraminidase Inhibitor Sales (K Units) by Type (2026-2031)

Table 52. Global Neuraminidase Inhibitor Sales Market Share by Type (2020-2025)

Table 53. Global Neuraminidase Inhibitor Sales Market Share by Type (2026-2031)

Table 54. Global Neuraminidase Inhibitor Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Neuraminidase Inhibitor Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Neuraminidase Inhibitor Revenue Market Share by Type (2020-2025)

Table 57. Global Neuraminidase Inhibitor Revenue Market Share by Type (2026-2031)

Table 58. Global Neuraminidase Inhibitor Price (US$/Unit) by Type (2020-2025)

Table 59. Global Neuraminidase Inhibitor Price (US$/Unit) by Type (2026-2031)

Table 60. Global Neuraminidase Inhibitor Sales (K Units) by Application (2020-2025)

Table 61. Global Neuraminidase Inhibitor Sales (K Units) by Application (2026-2031)

Table 62. Global Neuraminidase Inhibitor Sales Market Share by Application (2020-2025)

Table 63. Global Neuraminidase Inhibitor Sales Market Share by Application (2026-2031)

Table 64. Global Neuraminidase Inhibitor Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Neuraminidase Inhibitor Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Neuraminidase Inhibitor Revenue Market Share by Application (2020-2025)

Table 67. Global Neuraminidase Inhibitor Revenue Market Share by Application (2026-2031)

Table 68. Global Neuraminidase Inhibitor Price (US$/Unit) by Application (2020-2025)

Table 69. Global Neuraminidase Inhibitor Price (US$/Unit) by Application (2026-2031)

Table 70. GlaxoSmithKline Company Information

Table 71. GlaxoSmithKline Description and Business Overview

Table 72. GlaxoSmithKline Neuraminidase Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. GlaxoSmithKline Neuraminidase Inhibitor Product

Table 74. GlaxoSmithKline Recent Developments/Updates

Table 75. Gilead Sciences Company Information

Table 76. Gilead Sciences Description and Business Overview

Table 77. Gilead Sciences Neuraminidase Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Gilead Sciences Neuraminidase Inhibitor Product

Table 79. Gilead Sciences Recent Developments/Updates

Table 80. F. Hoffman-La Roche Company Information

Table 81. F. Hoffman-La Roche Description and Business Overview

Table 82. F. Hoffman-La Roche Neuraminidase Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. F. Hoffman-La Roche Neuraminidase Inhibitor Product

Table 84. F. Hoffman-La Roche Recent Developments/Updates

Table 85. BioCryst Company Information

Table 86. BioCryst Description and Business Overview

Table 87. BioCryst Neuraminidase Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. BioCryst Neuraminidase Inhibitor Product

Table 89. BioCryst Recent Developments/Updates

Table 90. Daiichi Sankyo Company Information

Table 91. Daiichi Sankyo Description and Business Overview

Table 92. Daiichi Sankyo Neuraminidase Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Daiichi Sankyo Neuraminidase Inhibitor Product

Table 94. Daiichi Sankyo Recent Developments/Updates

Table 95. Key Raw Materials Lists

Table 96. Raw Materials Key Suppliers Lists

Table 97. Neuraminidase Inhibitor Distributors List

Table 98. Neuraminidase Inhibitor Customers List

Table 99. Neuraminidase Inhibitor Market Trends

Table 100. Neuraminidase Inhibitor Market Drivers

Table 101. Neuraminidase Inhibitor Market Challenges

Table 102. Neuraminidase Inhibitor Market Restraints

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

Table 106. Authors List of This Report

List of Figures

Figure 1. Product Picture of Neuraminidase Inhibitor

Figure 2. Global Neuraminidase Inhibitor Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Neuraminidase Inhibitor Market Share by Type: 2024 & 2031

Figure 4. Zanamivir Product Picture

Figure 5. Oseltamivir Product Picture

Figure 6. Peramivir Product Picture

Figure 7. Laninamivir Product Picture

Figure 8. Global Neuraminidase Inhibitor Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Neuraminidase Inhibitor Market Share by Application: 2024 & 2031

Figure 10. Hospital Pharmacies

Figure 11. Drug Stores

Figure 12. Retail Stores

Figure 13. Others

Figure 14. Global Neuraminidase Inhibitor Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Neuraminidase Inhibitor Market Size (2020-2031) & (US$ Million)

Figure 16. Global Neuraminidase Inhibitor Sales (2020-2031) & (K Units)

Figure 17. Global Neuraminidase Inhibitor Average Price (US$/Unit) & (2020-2031)

Figure 18. Neuraminidase Inhibitor Report Years Considered

Figure 19. Neuraminidase Inhibitor Sales Share by Manufacturers in 2024

Figure 20. Global Neuraminidase Inhibitor Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest Neuraminidase Inhibitor Players: Market Share by Revenue in Neuraminidase Inhibitor in 2024

Figure 22. Neuraminidase Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global Neuraminidase Inhibitor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America Neuraminidase Inhibitor Sales Market Share by Country (2020-2031)

Figure 25. North America Neuraminidase Inhibitor Revenue Market Share by Country (2020-2031)

Figure 26. United States Neuraminidase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada Neuraminidase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe Neuraminidase Inhibitor Sales Market Share by Country (2020-2031)

Figure 29. Europe Neuraminidase Inhibitor Revenue Market Share by Country (2020-2031)

Figure 30. Germany Neuraminidase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France Neuraminidase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. Neuraminidase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy Neuraminidase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia Neuraminidase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Neuraminidase Inhibitor Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific Neuraminidase Inhibitor Revenue Market Share by Region (2020-2031)

Figure 37. China Neuraminidase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan Neuraminidase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea Neuraminidase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India Neuraminidase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia Neuraminidase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. China Taiwan Neuraminidase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Indonesia Neuraminidase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Thailand Neuraminidase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Malaysia Neuraminidase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Neuraminidase Inhibitor Sales Market Share by Country (2020-2031)

Figure 47. Latin America Neuraminidase Inhibitor Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Neuraminidase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Neuraminidase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Neuraminidase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Neuraminidase Inhibitor Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Neuraminidase Inhibitor Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Neuraminidase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Neuraminidase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. UAE Neuraminidase Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Neuraminidase Inhibitor by Type (2020-2031)

Figure 57. Global Revenue Market Share of Neuraminidase Inhibitor by Type (2020-2031)

Figure 58. Global Neuraminidase Inhibitor Price (US$/Unit) by Type (2020-2031)

Figure 59. Global Sales Market Share of Neuraminidase Inhibitor by Application (2020-2031)

Figure 60. Global Revenue Market Share of Neuraminidase Inhibitor by Application (2020-2031)

Figure 61. Global Neuraminidase Inhibitor Price (US$/Unit) by Application (2020-2031)

Figure 62. Neuraminidase Inhibitor Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Neuraminidase Inhibitors Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Zanamivir Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Influenza Therapeutics Market Insights Forecast to 2030

Global Antiviral Drugs for Influenza Market Research Report 2025

Influenza Antiviral Drugs Market

Global Neuraminidase Assay Kit Market Research Report 2024

Global Oseltamivir Phosphate API Market Research Report 2025

Anti influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Influenza Drugs and Vaccines Market Research Report 2025

Global Oseltamivir Market Insights Forecast to 2030

Global Influenza Flu Antiviral Drugs Market Insights Forecast to 2030

Global Anti Influenza Virus Chinese Medicine Market Research Report 2024

Influenza H3N2 Hemagglutinin ELISA Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Respiratory Antiviral Treatment Market Research Report 2024

Global Influenza Virus Kits Market Research Report 2024

Global Influenza A Virus Antigen Detection Kits Market Research Report 2024

Global Vaccine for Influenza Market Research Report 2025

Global RNase Inhibitor Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions